APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis A Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025183 pages

Choose your research edition.

Industry ResearchHepatitis A Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis A Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis A Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis A Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Hepatitis A Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hepatitis A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hepatitis A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepatitis A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hepatitis A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hepatitis A Vaccine include GSK, Zhejiang Pukang, Changchun Institute of Biological, IMBCAMS, Sanofi, Merck, Convac, Sinovac and KM Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hepatitis A Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hepatitis A Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hepatitis A Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hepatitis A Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Hepatitis A Vaccine Segment by Company

GSK

Zhejiang Pukang

Changchun Institute of Biological

IMBCAMS

Sanofi

Merck

Convac

Sinovac

KM Biologics

Hepatitis A Vaccine Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Hepatitis A Vaccine Segment by Application

Government Institution

Private Sector

Other

Hepatitis A Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hepatitis A Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hepatitis A Vaccine Industry Trends Table 2. Hepatitis A Vaccine Industry Drivers Table 3. Hepatitis A Vaccine Industry Opportunities and Challenges Table 4. Hepatitis A Vaccine Industry Restraints Table 5. Global Hepatitis A Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hepatitis A Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hepatitis A Vaccine Sales Market Share by Manufacturers Table 9. Global Hepatitis A Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hepatitis A Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hepatitis A Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hepatitis A Vaccine Manufacturers, Product Type & Application Table 13. Global Hepatitis A Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hepatitis A Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Vaccine Table 17. Major Manufacturers of Live Attenuated Vaccine Table 18. Global Hepatitis A Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Hepatitis A Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Hepatitis A Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Hepatitis A Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Hepatitis A Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hepatitis A Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Hepatitis A Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Hepatitis A Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Hepatitis A Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Government Institution Table 29. Major Manufacturers of Private Sector Table 30. Major Manufacturers of Other Table 31. Global Hepatitis A Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Hepatitis A Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Hepatitis A Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Hepatitis A Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Hepatitis A Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Hepatitis A Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Hepatitis A Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Hepatitis A Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Hepatitis A Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Hepatitis A Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hepatitis A Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Hepatitis A Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Hepatitis A Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Hepatitis A Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Hepatitis A Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Hepatitis A Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Hepatitis A Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Hepatitis A Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Hepatitis A Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hepatitis A Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Hepatitis A Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Hepatitis A Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Hepatitis A Vaccine Revenue Market Share by Region (2027-2032) Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. GSK Hepatitis A Vaccine Product Portfolio Table 67. GSK Recent Development Table 68. Zhejiang Pukang Company Information Table 69. Zhejiang Pukang Business Overview Table 70. Zhejiang Pukang Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Zhejiang Pukang Hepatitis A Vaccine Product Portfolio Table 72. Zhejiang Pukang Recent Development Table 73. Changchun Institute of Biological Company Information Table 74. Changchun Institute of Biological Business Overview Table 75. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio Table 77. Changchun Institute of Biological Recent Development Table 78. IMBCAMS Company Information Table 79. IMBCAMS Business Overview Table 80. IMBCAMS Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. IMBCAMS Hepatitis A Vaccine Product Portfolio Table 82. IMBCAMS Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sanofi Hepatitis A Vaccine Product Portfolio Table 87. Sanofi Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merck Hepatitis A Vaccine Product Portfolio Table 92. Merck Recent Development Table 93. Convac Company Information Table 94. Convac Business Overview Table 95. Convac Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Convac Hepatitis A Vaccine Product Portfolio Table 97. Convac Recent Development Table 98. Sinovac Company Information Table 99. Sinovac Business Overview Table 100. Sinovac Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sinovac Hepatitis A Vaccine Product Portfolio Table 102. Sinovac Recent Development Table 103. KM Biologics Company Information Table 104. KM Biologics Business Overview Table 105. KM Biologics Hepatitis A Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. KM Biologics Hepatitis A Vaccine Product Portfolio Table 107. KM Biologics Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Hepatitis A Vaccine Distributors List Table 111. Hepatitis A Vaccine Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Hepatitis A Vaccine Product Image Figure 2. Global Hepatitis A Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis A Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatitis A Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Hepatitis A Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hepatitis A Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Vaccine Image Figure 9. Live Attenuated Vaccine Image Figure 10. Global Hepatitis A Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hepatitis A Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hepatitis A Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Hepatitis A Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hepatitis A Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hepatitis A Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Government Institution Image Figure 17. Private Sector Image Figure 18. Other Image Figure 19. Global Hepatitis A Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Hepatitis A Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hepatitis A Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Hepatitis A Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hepatitis A Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hepatitis A Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Hepatitis A Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Hepatitis A Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Hepatitis A Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Hepatitis A Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Hepatitis A Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Hepatitis A Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Hepatitis A Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hepatitis A Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Hepatitis A Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GSK
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • IMBCAMS
  • Sanofi
  • Merck
  • Convac
  • Sinovac
  • KM Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hepatitis A Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hepatitis A Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hepatitis A Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hepatitis A Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hepatitis A Vaccine Market Dynamics
  1. 2.1 Hepatitis A Vaccine Industry Trends
  2. 2.2 Hepatitis A Vaccine Industry Drivers
  3. 2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
  4. 2.4 Hepatitis A Vaccine Industry Restraints
3 Hepatitis A Vaccine Market by Manufacturers
  1. 3.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hepatitis A Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hepatitis A Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hepatitis A Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatitis A Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hepatitis A Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Hepatitis A Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatitis A Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatitis A Vaccine Tier 1, Tier 2, and Tier 3
4 Hepatitis A Vaccine Market by Type
  1. 4.1 Hepatitis A Vaccine Type Introduction
  2. 4.1.1 Inactivated Vaccine
  3. 4.1.2 Live Attenuated Vaccine
  4. 4.2 Global Hepatitis A Vaccine Sales by Type
  5. 4.2.1 Global Hepatitis A Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hepatitis A Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Hepatitis A Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hepatitis A Vaccine Revenue by Type
  9. 4.3.1 Global Hepatitis A Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hepatitis A Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2021-2032)
5 Hepatitis A Vaccine Market by Application
  1. 5.1 Hepatitis A Vaccine Application Introduction
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Hepatitis A Vaccine Sales by Application
  6. 5.2.1 Global Hepatitis A Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hepatitis A Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Hepatitis A Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hepatitis A Vaccine Revenue by Application
  10. 5.3.1 Global Hepatitis A Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hepatitis A Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2021-2032)
6 Global Hepatitis A Vaccine Sales by Region
  1. 6.1 Global Hepatitis A Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hepatitis A Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Hepatitis A Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Hepatitis A Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hepatitis A Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hepatitis A Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hepatitis A Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hepatitis A Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hepatitis A Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hepatitis A Vaccine Revenue by Region
  1. 7.1 Global Hepatitis A Vaccine Revenue by Region
  2. 7.1.1 Global Hepatitis A Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hepatitis A Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Hepatitis A Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Hepatitis A Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hepatitis A Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hepatitis A Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hepatitis A Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hepatitis A Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hepatitis A Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Hepatitis A Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Zhejiang Pukang
  8. 8.2.1 Zhejiang Pukang Company Information
  9. 8.2.2 Zhejiang Pukang Business Overview
  10. 8.2.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
  12. 8.2.5 Zhejiang Pukang Recent Developments
  13. 8.3 Changchun Institute of Biological
  14. 8.3.1 Changchun Institute of Biological Company Information
  15. 8.3.2 Changchun Institute of Biological Business Overview
  16. 8.3.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
  18. 8.3.5 Changchun Institute of Biological Recent Developments
  19. 8.4 IMBCAMS
  20. 8.4.1 IMBCAMS Company Information
  21. 8.4.2 IMBCAMS Business Overview
  22. 8.4.3 IMBCAMS Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 IMBCAMS Hepatitis A Vaccine Product Portfolio
  24. 8.4.5 IMBCAMS Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Hepatitis A Vaccine Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Hepatitis A Vaccine Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Convac
  38. 8.7.1 Convac Company Information
  39. 8.7.2 Convac Business Overview
  40. 8.7.3 Convac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Convac Hepatitis A Vaccine Product Portfolio
  42. 8.7.5 Convac Recent Developments
  43. 8.8 Sinovac
  44. 8.8.1 Sinovac Company Information
  45. 8.8.2 Sinovac Business Overview
  46. 8.8.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sinovac Hepatitis A Vaccine Product Portfolio
  48. 8.8.5 Sinovac Recent Developments
  49. 8.9 KM Biologics
  50. 8.9.1 KM Biologics Company Information
  51. 8.9.2 KM Biologics Business Overview
  52. 8.9.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 KM Biologics Hepatitis A Vaccine Product Portfolio
  54. 8.9.5 KM Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hepatitis A Vaccine Value Chain Analysis
  2. 9.1.1 Hepatitis A Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hepatitis A Vaccine Production Mode & Process
  6. 9.2 Hepatitis A Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hepatitis A Vaccine Distributors
  9. 9.2.3 Hepatitis A Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst